Cel-Sci
CVM
#10574
Rank
A$48.86 M
Marketcap
A$2.78
Share price
-0.51%
Change (1 day)
-81.83%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2026 (TTM): -A$32.84 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$33.29 Million, an increase over its 2024 earnings that were of -A$38.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$32.84 Million-1.34%
2025 -A$33.29 Million-12.52%
2024 -A$38.05 Million-12.41%
2023 -A$43.44 Million-12.87%
2022 -A$49.85 Million-3.42%
2021 -A$51.62 Million13.44%
2020 -A$45.5 Million11.28%
2019 -A$40.89 Million179.81%
2018 -A$14.62 Million-48.72%
2017 -A$28.5 Million-16.23%
2016 -A$34.02 Million-23.63%
2015 -A$44.55 Million-5.47%
2014 -A$47.13 Million198.49%
2013 -A$15.79 Million
2010 -A$18.43 Million
2004 -A$6.23 Million12.38%
2003 -A$5.55 Million-16.59%
2002 -A$6.65 Million-59.28%
2001 -A$16.32 Million23.17%
2000 -A$13.25 Million20.12%
1999 -A$11.03 Million13.24%
1998 -A$9.74 Million-20%
1997 -A$12.18 Million46.55%
1996 -A$8.31 Million34.88%
1995 -A$6.16 Million2.38%
1994 -A$6.02 Million68%
1993 -A$3.59 Million78.57%
1992 -A$2.01 Million180%
1991 -A$0.72 Million25%
1990 -A$0.58 Million-0%
1989 -A$0.58 Million-71.43%
1988 -A$2.01 Million-0%
1987 -A$2.01 Million-46.15%
1986 -A$3.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.52 B-117,837.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.73 B-46,313.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.24 Billion 622.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$12.1 Million-62.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.29 B-7,310.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-A$0.55 Billion 1,612.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 327.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$23.66 Million-25.78%๐Ÿ‡บ๐Ÿ‡ธ USA